PREvention of Atrial Fibrillation in patientS Undergoing thorAcic surGEry for Lung Cancer
Status:
Completed
Trial end date:
2013-10-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to assess whether prophylactic treatment with metoprolol or losartan
is able to reduce the incidence of atrial fibrillation (AF) in patients undergoing thoracic
surgery for lung cancer, showing elevated plasma levels in NT probrain natriuretic peptide
(NT-proBNP), measured in the perioperative period.
Phase:
Phase 3
Details
Lead Sponsor:
European Institute of Oncology
Treatments:
Angiotensin II Angiotensin Receptor Antagonists Angiotensin-Converting Enzyme Inhibitors Losartan Metoprolol